uric acid has been researched along with naringenin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Derendorf, H; Jilma-Stohlawetz, P; Meibohm, B; Mertens-Talcott, SU; Pacheco-Palencia, LA; Rios, J; Talcott, ST | 1 |
Prabu, SM; Renugadevi, J | 1 |
Chen, KC; Hsieh, CL; Ker, YB; Peng, CC; Peng, RY; Wang, HY | 1 |
Klivényi, P; Plangár, I; Szalárdy, L; Vécsei, L; Zádori, D | 1 |
1 trial(s) available for uric acid and naringenin
Article | Year |
---|---|
Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers.
Topics: Adult; Anthocyanins; Antioxidants; Arecaceae; Cross-Over Studies; Flavanones; Fruit; Glucosides; Humans; Reactive Oxygen Species; Uric Acid | 2008 |
3 other study(ies) available for uric acid and naringenin
Article | Year |
---|---|
Naringenin protects against cadmium-induced oxidative renal dysfunction in rats.
Topics: Animals; Antioxidants; Cadmium Chloride; Creatinine; Flavanones; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Urea; Uric Acid | 2009 |
Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease.
Topics: Albuminuria; Animals; bcl-2-Associated X Protein; bcl-Associated Death Protein; Blood Urea Nitrogen; Caspase 3; Catechin; Cholesterol; Creatinine; Dietary Supplements; Doxorubicin; Flavanones; Glomerular Filtration Rate; In Situ Nick-End Labeling; Insulin; Kidney; Male; Malondialdehyde; Oxidative Stress; PPAR alpha; Quercetin; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Rutin; Superoxide Dismutase; Triglycerides; Uric Acid | 2012 |
Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Allopurinol; Animals; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Drug Administration Schedule; Flavanones; Homovanillic Acid; Infusions, Parenteral; Male; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neurotoxins; Oxidative Stress; Parkinson Disease; Silymarin; Sulfinpyrazone; Uric Acid | 2013 |